Medical Journals

Nspc1 is a Cell Growth Regulator That Acts As a Transcriptional Repressor of P21waf1/Cip1 Via the Rare Element.

Authors:
  • Gong Yanhua
  • Yue Jiping
  • Wu Xudong
  • Wang Xu
  • Wen Jianyan
  • Lu Lifang
  • Peng Xiaozhong
  • Qiang Boqin
  • Yuan Jiangang

From: National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, National Human Genome Center, Beijing 100005, China.

Nucleic acids research

  • Publish Date: 2006
  • ISSN: 1362-4962
  • Volume: 34
  • Issue: 21
  • Pages: 6158-69
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Gong Yanhua, Yue Jiping, Wu Xudong, et al. Nspc1 is a Cell Growth Regulator That Acts As a Transcriptional Repressor of P21waf1/Cip1 Via the Rare Element.. Nucleic Acids Res. 2006;34:6158-69

Abstract

The mammalian polycomb group proteins play an important role in cell cycle control and tumorigenesis. Nervous system polycomb 1 (NSPc1) is a newly identified transcription repressor, highly homologous with PcG protein Bmi-1. In this article, we showed that NSPc1 could promote tumor cell cycle progression and cell proliferation. Semi-quantitative RT-PCR showed that NSPc1 did not affect the expression levels of most Cyclin-depentent kinases (CDK) inhibitors except for p21Waf1/Cip1. Repression activity assays, chromatin immunoprecipitation (ChIP) and DNA pulldown assays all verified that NSPc1 represses the expression of p21Waf1/Cip1 by binding to the (-1357 to -1083) region of the p21Waf1/Cip1 promoter in vivo, and the repression effect is dependent on the retinoid acid response element (RARE element) within the above region of the p21Waf1/Cip1 promoter. Further analysis showed that NSPc1 could compete the RARE element site with RA receptors both in vitro and in vivo. Taken together, our results support the hypothesis that NSPc1 has a positive role in tumor cell growth by down-regulating p21Waf1/Cip1 via the RARE element, which directly connects transcriptional repression of PcGs to CDKIs and RA signaling pathways.

Mesh Headings (Keywords): Animals, Binding Sites, Carrier Proteins, Cell Cycle, Cell Line, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Gene Expression Regulation, Neoplastic, Hela Cells, Humans, Neoplasms, Promoter Regions (Genetics), Repressor Proteins, Response Elements, Retinoid X Receptor alpha, Ubiquitin-Protein Ligases


Check for Full Text / PubMed Unique Identifier (PMID): 17088287


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.